Condition
Bronchopulmonary Dysplasia clinical trials and research
As of November 12, 2026, Find a Trial lists 28 Bronchopulmonary Dysplasia clinical trials that are recruiting, at sites in 13 countries (most in United States (18), Belgium (3), Italy (3)). By phase: Phase 2 (4), Phase 1 (3), Phase 1/2 (2), Phase 2/3 (1). The most active sponsors are University of Alabama at Birmingham (3), Children's Mercy Hospital Kansas City (2), International Peace Maternity and Child Health Hospital (2). There are also 36 NIH-funded research projects on Bronchopulmonary Dysplasia, with $18.8 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 28Clinical trials
- 36NIH research projects
- 13Countries
Newest Bronchopulmonary Dysplasia clinical trials
All recruiting trials (28)
-
Lung Ultrasound Score to predict BPD in very preterm babies
This study tests whether lung ultrasound scores in the first two weeks of life can predict which extremely preterm babies will develop bronchopulmonary dysplasia.
-
Caffeine in pregnancy: how the mother and baby handle it during delivery
This study tests how caffeine is processed in pregnant people and how much reaches the baby when given shortly before delivery.
-
IVIG for bronchopulmonary dysplasia in infants born at 28 weeks or earlier
This trial will try intravenous immunoglobulin (IVIG) given over five days to see if it helps very preterm infants (≤28 weeks) who show early signs of bronchopulmonary dysplasia.
-
High-energy DHA/ARA-enriched human milk in the first 2 weeks to lower lung problems in extremely preterm babies
This trial tests whether giving DHA/ARA-enriched, fortified human milk in the first 14 days after birth helps extremely preterm infants breathe easier and have better lung function.
-
Reduced versus higher daily fluids to prevent bronchopulmonary dysplasia in very preterm babies
This tests whether giving smaller daily fluid volumes from day 8 of life (about 135 mL/kg/day) instead of larger volumes (about 165 mL/kg/day) lowers the chance of developing BPD or dying before 36 weeks in babies born before 30 weeks.
-
Using IVIG to treat bronchopulmonary dysplasia in premature infants
This study is testing if a special immune treatment called IVIG can help premature babies with breathing problems caused by bronchopulmonary dysplasia feel better.
-
Comparing two IV lipid infusions for very preterm or very low birth weight infants
This study will try two types of intravenous lipid emulsions (mixed-oil vs soybean-oil) in extremely preterm or very low birth weight infants to see which better prevents bronchopulmonary dysplasia and supports growth and brain development.
-
Zelpultide Alfa to reduce bronchopulmonary dysplasia risk in extremely premature babies
This trial will try Zelpultide Alfa in extremely premature infants on ventilators to see if it lowers their chance of developing bronchopulmonary dysplasia.
-
Comparing gastric and transpyloric feeding in infants with severe bronchopulmonary dysplasia
This study is testing whether feeding hospitalized infants with severe bronchopulmonary dysplasia through their stomach or directly into their intestines helps improve their breathing better.
-
Inhaled ciclesonide for preterm infants at risk of lung disease
This study is testing if inhaled ciclesonide is a safer option than traditional treatments for preventing lung disease in preterm infants born before 30 weeks.
-
Using pressure-sensing mattresses to monitor breathing in newborns
This study is testing if special pressure-sensing mattresses can help monitor breathing and heart rate in premature babies receiving breathing support, to see if they can predict breathing problems more comfortably than traditional methods.
-
Transpyloric versus gastric feeding for premature infants with bronchopulmonary dysplasia
This trial will see if feeding premature infants with bronchopulmonary dysplasia directly into the small intestine (transpyloric) versus into the stomach reduces reflux and episodes of low oxygen.
-
Adjusting ventilator PEEP to improve lung compliance and heart function in preterm infants
We will try changing the ventilator's PEEP settings in babies born before 34 weeks who need breathing support to see if the PEEP that gives the best lung compliance improves heart output and oxygen levels.
-
Classification of severe bronchopulmonary dysplasia in infants
This study is trying to create a new way to classify the most severe form of bronchopulmonary dysplasia in infants to see how different types of the condition affect their breathing and brain development over time.
-
Comparing higher versus lower oxygen targets for very preterm infants with BPD-related pulmonary hypertension
This trial will see if keeping very preterm infants with bronchopulmonary dysplasia and pulmonary hypertension at a slightly higher oxygen saturation (95–98%) versus a lower saturation (92–95%) helps them do better.
-
Investigating biomarkers for early prediction of bronchopulmonary dysplasia in preterm infants
This study is trying to find early signs that can help predict if premature babies will develop bronchopulmonary dysplasia, using samples from their breath, throat, and placenta.
-
Using extracellular vesicles to prevent lung disease in premature infants
This study is testing a new treatment using special cells from umbilical cords to see if it can help prevent lung disease in very premature infants.
-
Using stem cells to treat lung disease in preterm newborns
This study is testing if giving preterm newborns stem cells from umbilical cords can help prevent lung disease called bronchopulmonary dysplasia while they are on breathing machines.
-
Standardized oral care using human milk for premature infants in the NICU
This study is trying to see if giving regular oral care using human milk can help very low birth weight babies in the NICU stay healthier and avoid complications.
-
Optimizing oxygen levels for premature infants during resuscitation
This study is testing which oxygen level is best for helping premature babies during resuscitation at birth to improve their chances of survival and long-term health.
-
Postpyloric feedings to improve lung health in preterm infants
This study is testing if feeding preterm infants directly into their intestines can help improve their lung health better than regular feeding through the nose.
-
Comparing two non-invasive ventilation methods for preterm infants after extubation
This study is testing whether a new breathing support method is better than a standard one for extremely preterm infants who are coming off a ventilator to see if it helps them avoid complications.
-
Improving discharge care for preterm infants with lung disease
This study is testing a new care plan for preterm infants with lung disease to see if it helps them transition better from the hospital to home and improves their health and parents' satisfaction.
-
Understanding how drugs work in children
This study is trying to find the best and safest doses of certain medications for children and young adults under 21 who are being treated for conditions like COVID-19 and pulmonary arterial hypertension.
-
Measuring lung function in infants with bronchopulmonary dysplasia
This study is testing a new device to measure lung function in sleeping infants with bronchopulmonary dysplasia to help better understand their breathing problems.
-
Evaluating a new imaging system for pediatric respiratory diseases
This study is testing a new imaging system to see if it can help monitor breathing in children with respiratory diseases and compare it to healthy kids.
-
Using MRI to study lung development in infants with Bronchopulmonary Dysplasia
This study is testing how MRI scans can help us understand lung development in premature infants with Bronchopulmonary Dysplasia by comparing them to infants without the condition.
-
Using stem cells to prevent lung disease in premature infants
This study is testing if giving special stem cells from umbilical cords can help prevent lung disease in premature babies who are at high risk.
NIH-funded research (36)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
Role of uneven lung growth in chronic lung disease from birth to adulthood
This grant explores how mismatched growth of airways, airspaces, and blood vessels during early life might lead to lasting lung problems in bronchopulmonary dysplasia and how that affects people over time.
-
Regulatory T Cells and Lung Disease-Related High Blood Pressure in Adults
This project studies how a type of immune cell called regulatory T cells may influence inflammation and blood vessel changes in lung disease, with potential relevance to adults who have vascular issues in their lungs.
-
Understanding how breathing effort in premature babies with lung disease comes from different lung problems
A research project aims to create a patient-specific tool to measure how different features of bronchopulmonary dysplasia contribute to the struggle to breathe in premature infants.
-
Role of LKB1 in reduced lung blood vessel growth in BPD
Aims to understand how a cellular regulator (LKB1) affects blood vessel formation in the lungs of preterm infants at risk for bronchopulmonary dysplasia.
-
A new approach to prevent bronchopulmonary dysplasia in preterm infants
A new treatment strategy aimed at improving lung development in premature babies at risk for bronchopulmonary dysplasia.
-
L-Citrulline for BPD-related Pulmonary Hypertension in Preterm Babies
A first-in-human study will test safe and effective doses of L-citrulline given by mouth to stability-preterm infants at risk for lung blood pressure problems.
-
Metabolic clues to BPD-related pulmonary hypertension in babies and teens and adults
This grant aims to understand why a serious lung condition in preterm babies can lead to high blood pressure in the lungs, with the goal of finding new treatments.
-
Developing a new treatment for bronchopulmonary dysplasia in infants
This study is working on a new medicine to help treat bronchopulmonary dysplasia (BPD) in premature babies, and the researchers are making sure it’s safe to test in humans so that it can eventually be available to those who need it.
-
AVR-48: a new lung medicine to help premature babies prevent lung disease
A small molecule medicine called AVR-48 is being studied to help premature babies avoid a serious lung disease called bronchopulmonary dysplasia.
-
DLL4 and newborn lung development in bronchopulmonary dysplasia
This work looks at whether restoring a protein called DLL4 can help blood vessel and air sac growth in premature babies with bronchopulmonary dysplasia (BPD).
-
Role of Surfactant Protein A and SP-R210 Signaling in Bronchopulmonary Dysplasia
This NIH grant focuses on how surfactant protein A and its receptor in lung immune cells contribute to bronchopulmonary dysplasia in premature babies.
-
Parent-reported breathing and care issues when preterm babies with BPD go home
This project collects parents' reports to find breathing problems and care barriers for preterm infants with bronchopulmonary dysplasia as they leave the NICU and enter early childhood.
-
New treatments for lung problems in premature infants
This study is looking for new ways to help premature babies who have bronchopulmonary dysplasia and high blood pressure in their lungs, with the goal of making them healthier and reducing serious health risks.
-
How different lung problems add to breathing effort in premature babies with bronchopulmonary dysplasia
This project will build a tool that estimates how much each lung problem makes a premature baby with bronchopulmonary dysplasia work harder to breathe.
-
How the LKB1 protein affects blood vessel and lung growth in babies with bronchopulmonary dysplasia
This research is seeing if targeting a cell energy protein (LKB1/AMPK) can help restore blood vessel and lung growth in premature infants at risk for bronchopulmonary dysplasia.
-
Understanding how metabolic processes affect lung disease in premature infants
This study is looking at how certain changes in the lungs of premature babies with bronchopulmonary dysplasia can lead to high blood pressure in the lungs, and it hopes to find new ways to help treat or prevent this condition.
-
Investigating a new treatment to prevent lung disease in premature infants
This study is testing a new medication called AVR-48 to see if it can help prevent lung problems in premature babies, aiming to improve their breathing and overall health.
-
Using aerosolized vitamin A to help prevent lung injury in premature infants
This study is testing a gentle way to give preterm babies a special vitamin A mist to help prevent lung problems and vitamin A deficiency, so they can avoid painful shots and get the nutrients they need more easily.
-
Understanding how to improve care for infants with bronchopulmonary dysplasia as they transition from the NICU to home
This study is all about finding better ways to support families of babies with bronchopulmonary dysplasia (BPD) as they transition from the hospital to home, by understanding their challenges and creating helpful tools to improve their health and care.
-
Investigating the role of DLL4 in lung development and bronchopulmonary dysplasia in premature infants
This study is looking at how a protein called DLL4 impacts lung growth in premature babies, especially those at risk for a serious lung problem called bronchopulmonary dysplasia (BPD), to find ways to help their lungs develop better.
-
Identifying kidney-related risk factors for severe lung disease in premature infants
This study is looking at how kidney problems and too much fluid can lead to serious lung issues in premature babies, and it aims to help doctors spot which babies might be at risk so they can provide better care and improve their health.
-
Comparing two feeding methods for very preterm infants with lung disease
This study is looking at whether feeding very premature babies through a different route (transpyloric feeding) instead of the usual method (gastric feeding) can help improve their health and reduce problems like reflux, especially for those with a serious lung condition called bronchopulmonary dysplasia (BPD).
-
Investigating how liver kinase B1 affects blood vessel growth in premature infants with lung complications
This study is exploring how too much oxygen can affect the lung growth of premature babies with bronchopulmonary dysplasia, and it’s looking at a specific protein that might help improve blood vessel development in their lungs to find better treatments for them.
-
Investigating a factor in lung development and its role in a common neonatal lung disease
This study is looking at how a protein called CCN2 helps newborns' lungs grow and heal, with the goal of finding new ways to treat bronchopulmonary dysplasia (BPD) in premature babies.
-
Using saliva to predict lung complications in premature infants
This study is looking at how tiny molecules in saliva might help doctors predict lung problems in premature babies, so they can catch issues early and provide better care.
-
Investigating furosemide treatment strategies for severe bronchopulmonary dysplasia in infants
This study is looking at how different amounts and lengths of a medicine called furosemide can help improve the health of premature babies with a serious lung condition called bronchopulmonary dysplasia (BPD).
-
Creating a new treatment for bronchopulmonary dysplasia in preterm infants
This study is testing a new treatment for bronchopulmonary dysplasia (BPD) in preterm babies, using a special compound that helps reduce lung stress and inflammation, with the hope of making their lungs healthier and improving their overall well-being.
-
The connection between gut health and lung development in newborns
This study is looking at how tiny fungi in the gut might influence lung health in newborns, especially those at risk for bronchopulmonary dysplasia (BPD), to help find better treatments for these little ones.
-
Investigating how IL-33 affects lung injury in premature infants
This study is looking at how a protein called IL-33 might be linked to lung problems in premature babies with bronchopulmonary dysplasia (BPD), and the researchers hope to find new ways to help these little ones breathe better.
-
Understanding breathing difficulties in premature babies with lung disease
This study is looking at babies who were born early and have breathing problems called bronchopulmonary dysplasia (BPD), and it aims to create a helpful tool that will figure out how their lungs work so doctors can give them the best care for their specific breathing needs.
-
Understanding lung disease in premature infants through metabolic changes
This study is looking at how the metabolism of preterm babies with bronchopulmonary dysplasia (BPD) changes over time by collecting and analyzing their urine and lung fluid, with the goal of finding better ways to care for these little ones.
-
Investigating how vitamin D affects lung development and chronic lung disease in infants
This study is looking at how vitamin D might help improve lung development in premature babies and protect them from a lung condition called bronchopulmonary dysplasia (BPD), using mouse models to learn more about how it works.
-
Investigating the safety of sildenafil for premature infants with severe lung disease
This study is looking at whether sildenafil can safely help prevent lung problems in premature babies with severe breathing issues, and it involves giving some babies the medication and others a placebo to see how well it works.
-
Testing inhaled tobramycin for very preterm infants with lung disease
This study is looking at how inhaled tobramycin, an antibiotic, can help very preterm babies with bronchopulmonary dysplasia (BPD) by delivering the medicine straight to their lungs to fight harmful bacteria and improve their breathing.
-
How indoor air quality affects children with lung issues from premature birth
This study looks at how the air quality inside homes affects the breathing health of school-aged kids with bronchopulmonary dysplasia, a lung condition from being born early, to find ways to help them breathe better.
-
Inhaled treatment for chronic lung disease in infants
This study is looking at how inhaling ethyl nitrite might help improve lung function and oxygen levels in premature babies with bronchopulmonary dysplasia, a serious lung condition, by making their lungs work better.
Related topics
Quick answers
How many Bronchopulmonary Dysplasia clinical trials are recruiting right now?
28, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 13 countries. The most sites are in United States (18 trials), Belgium (3 trials), Italy (3 trials), Taiwan (2 trials), Canada (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 4, Phase 1: 3, Phase 1/2: 2, Phase 2/3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.